Fady Hannah-Shmouni, MD, FRCPC
Physician, Investor, Venture Builder. Engineering the future of healthspan.
Hi, I'm Fady, a physician investor with specialized expertise in endocrinology, hypertension, and genomic medicine.
I am a clinical endocrinologist and biochemical geneticist with a career dedicated to advancing precision medicine, genomics, and digital health. I serve as Founder & CEO of Hormonaly.ai, the agentic infrastructure for peptide, hormone, and longevity medicine — a clinical AI and EdTech platform providing GRADE-rated evidence synthesis and workflow tools for clinicians worldwide, as well as Strategic Advisor at FHS Capital and Assistant Clinical Professor at the University of British Columbia.
Earlier in my career, I led academic and clinical research programs at the National Institutes of Health (NIH), where my work focused on cortisol and growth hormone dysregulation. This research has contributed to more than 100 peer-reviewed publications, shaping global understanding of stress physiology, endocrine disorders, and their impact on human health and performance.
Today, I translate these scientific foundations into commercial innovation, helping medtech and biotech companies bridge advanced research with market-ready, scalable products that extend healthspan and optimize human potential. My investment and advisory portfolio includes Eli Health, Flyby, Science & Humans, Supernatural, Acorn, NU, AI Nexus, and Neurable, among others, companies pioneering the convergence of technology, biology, and artificial intelligence to redefine the future of human optimization.
As a full-stack AI builder, I specialize in agentic systems — architecting NVIDIA- and Google Cloud-based platforms for multi-agent orchestration, retrieval-augmented generation (RAG), agentic LMS, and digital twin analysis. This hands-on engineering expertise allows me to move fluidly from clinical evidence to production-grade AI infrastructure, designing systems that reason over medical knowledge at scale.
Building the next era of health.
Strategic roles across clinical AI, longevity medicine, and venture capital.
- Hormonaly.ai — Founder and CEO: the Evidence OS for peptide, hormone, and longevity medicine
- FHS Capital — Strategic Advisor: at FHS Capital investment firm
- Eli Health — Medical Director: biotech advancing real-time hormone monitoring
- Supernatural — Founding Partner: Canada's first fully integrated longevity space
- NU — Medical Advisor and Investor: multi-omics AI platform for personalized longevity
- Healthspan Digital — Founder and Chairman: of Healthspan Digital Holdings Limited
- DrVibe.ai — Co-Founder and Advisor: AI-powered longevity and health education platform
Academic & Clinical Journey
- — Founder & Chairman, DrVibe.ai — Agentic EdTech for Healthcare ★
- — Founder & CEO, Hormonaly.ai — The Evidence OS for Peptide, Hormone & Longevity Medicine ★
- — Director, AI Academy, Geneva College of Longevity Science (GCLS)
- — Faculty, Geneva College of Longevity Science
- — Assistant Clinical Professor, Department of Medicine, University of British Columbia
- — Founding Editor-In-Chief, Endocrine and Metabolic Science (Elsevier)
- — Principal Investigator, Adrenal and Growth Hormone disorders, NICHD, NIH
- — Director, Graduate Medical Education, NICHD, National Institutes of Health
- — Associate Program Director, NIH Endocrinology Fellowship Program
- — Associate Investigator, Adrenal and Growth Hormone disorders, NICHD, NIH
- — Fellowship in Clinical Biochemical Genetics, University of Toronto
- — Fellowship in Endocrinology & Metabolism, National Institutes of Health
- — Internal Medicine Residency, Yale School of Medicine
- — Research Assistant, Vancouver General Hospital, University of British Columbia
- — Medical Degree, University of Jordan School of Medicine
Awards
- — America's Best in Medicine Recognition
- — National Institutes of Health, NICHD Mentor Award
- — The Endocrine Society Outstanding Abstract
- — Joe. T. R Clarke Award for excellence in teaching, Department of Genetics and Metabolics, The Hospital for Sick Children, Univ of Toronto
- — The Endocrine Society Outstanding Abstract Award
- — Novo Nordisk, Inc. Travel Award for excellence in GH related research
- — Brownie and Schimmer New Investigator Poster Award, XVII Adrenal Cortex Conference
- — Outstanding PGY3 Resident, Yale-New Haven Medical Center, Yale School of Medicine
Publications & Media
- The Erewhon-ification of Medicine: Where Health Is a Status Symbol (May 21, 2026 · Press Release)
- Could Eating More Dark Chocolate Help Slow Down Biological Aging? (May 21, 2026 · Article)
- Can Chugging Raw Eggs Boost Your Testosterone? We Asked the Experts (Recent · Article)
- Harnessing AI and precision medicine to extend healthspan (Recent · Article)
Ready to shape the future of medicine?
For speaking engagements, clinical advisory, or venture partnerships.
Email: fady@shmouni.com